Skip to main content
Clinical Trials/ISRCTN61391164
ISRCTN61391164
Completed
未知

A randomized controlled trial of Concurrent treatment of PTSD and Substance Use Disorders using Prolonged Exposure (COPE) and Relapse Prevention (RP) in women with PTSD and Alcohol Use Disorder.

Rosenlunds sjukhus [Rosenlund Hospital]0 sites90 target enrollmentMarch 6, 2019

Overview

Phase
未知
Intervention
Not specified
Conditions
Post-traumatic stress disorder and alcohol use disorder
Sponsor
Rosenlunds sjukhus [Rosenlund Hospital]
Enrollment
90
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 6, 2019
End Date
May 10, 2021
Last Updated
4 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Rosenlunds sjukhus [Rosenlund Hospital]

Eligibility Criteria

Inclusion Criteria

  • 2\. Aged 18 years or older
  • 3\. Current PTSD and moderate to severe AUD, according to DSM\-5 and clinical assessment

Exclusion Criteria

  • 1\. Current moderate to severe SUD, other than alcohol and nicotine, according to DSM\-5
  • 2\. Current or not stably treated psychosis
  • 3\. Suicidal or homicidal ideation deemed to be in need of treatment before study treatment can start
  • 4\. Current medication, which may affect the study outcome, and which is deemed impossible to discontinue for the duration of the study, primarily AUD medication
  • 5\. Insufficient memory of the trauma (assessed using the CAPS\-5\)
  • 6\. Dissociation which is more difficult or affects the subject more than her PTSD
  • 7\. Somatic or psychiatric illness where it is deemed to not be in the subject’s best interest to participate in the study
  • 8\. IQ \< 70

Outcomes

Primary Outcomes

Not specified

Similar Trials